Regeneus Ltd.

Regeneus Ltd.
Stock Exchange Australian Stock Exchange
EPS
AUD0.02
Market Cap
AUD19.84 M
Shares Outstanding
208.89 M
Public Float
-

Profile

Address
25 Bridge Street
Pymble New South Wales (NSW) 2073
Australia
Employees -
Website http://www.regeneus.com.au
Updated 07/08/2019
Regeneus Ltd. is regenerative medicine company. It develops and commercializes innovative cell-based therapies to address unmet medical needs in human and veterinary health. The company was founded by Ben Herbert and Graham Vesey on August 14, 2007 and is headquartered in Pymble, Australia.

Financials

View All
Created with Highcharts 5.0.14Regeneus Ltd.Net Income. Fiscal year is July-June. All values AUD Thousands.7 5237 5236 6066 6063 5733 5733 2703 2705 1845 1842014201520162017201802k4k6k8k
Created with Highcharts 5.0.14Regeneus Ltd.Sales/Revenue. Fiscal year is July-June. All values AUD Thousands.1 9021 9021 8201 8201 7351 7359 9949 9945755752014201520162017201802.5k5k7.5k10k12.5k

John Martin
Chief Executive Officer & Executive Director
Graham Vesey
Executive Director & Chief Scientific Officer